Reduced metal ion concentrations in atherosclerotic plaques from subjects with Type 2 diabetes mellitus

Halliwell, 2007 Stocker, 2004, Role of oxidative modifications in atherosclerosis, Physiol Rev, 84, 1381, 10.1152/physrev.00047.2003 Stadler, 2004, Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper, Arterioscler Thromb Vasc Biol, 24, 949, 10.1161/01.ATV.0000124892.90999.cb Stanley, 2006, Concentrations of iron correlate with the extent of protein, but not lipid, oxidation in advanced human atherosclerotic lesions, Free Radic Biol Med, 40, 1636, 10.1016/j.freeradbiomed.2005.12.031 Raman, 2008, In vivo atherosclerotic plaque characterization using magnetic susceptibility distinguishes symptom-producing plaques, JACC Cardiovasc Imaging, 1, 49, 10.1016/j.jcmg.2007.09.002 Yuan, 2008, Iron involvement in multiple signaling pathways of atherosclerosis: a revisited hypothesis, Curr Med Chem, 15, 2157, 10.2174/092986708785747634 Sullivan, 1981, Iron and the sex difference in heart disease risk, Lancet, 1, 1293, 10.1016/S0140-6736(81)92463-6 Danesh, 1999, Coronary heart disease and iron status: meta-analyses of prospective studies, Circulation, 99, 852, 10.1161/01.CIR.99.7.852 Swaminathan, 2007, The role of iron in diabetes and its complications, Diabetes Care, 30, 1926, 10.2337/dc06-2625 Sullivan, 2009, Iron in arterial plaque: modifiable risk factor for atherosclerosis, Biochim Biophys Acta, 1790, 718, 10.1016/j.bbagen.2008.06.005 Rajpathak, 2009, The role of iron in type 2 diabetes in humans, Biochim Biophys Acta, 1790, 671, 10.1016/j.bbagen.2008.04.005 Pennathur, 2007, Mechanisms for oxidative stress in diabetic cardiovascular disease, Antioxid Redox Signal, 9, 955, 10.1089/ars.2007.1595 Hayden, 2003, Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stress, Cardiovasc Diabetol, 2, 2, 10.1186/1475-2840-2-2 Zacharski, 2004, Implementation of an iron reduction protocol in patients with peripheral vascular disease: VA cooperative study no. 410: the Iron (Fe) and Atherosclerosis Study (FeAST), Am Heart J, 148, 386, 10.1016/j.ahj.2004.03.027 Eshed, 2001, Plasma ferritin and type 2 diabetes mellitus: a critical review, Endocr Res, 27, 91, 10.1081/ERC-100107172 Freixenet, 2011, Men with hyperferritinemia and diabetes in the Mediterranean area do not have a higher iron overload than those without diabetes, Diabetes Res Clin Pract, 91, e33, 10.1016/j.diabres.2010.10.003 Hernandez, 2005, Soluble transferrin receptors and ferritin in Type 2 diabetic patients, Diabet Med, 22, 97, 10.1111/j.1464-5491.2004.01331.x Fernandez-Real, 2002, Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity, Diabetes Care, 25, 2249, 10.2337/diacare.25.12.2249 Virmani, 2000, Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions, Arterioscler Thromb Vasc Biol, 20, 1262, 10.1161/01.ATV.20.5.1262 Stadler, 2008, Accumulation of zinc in human atherosclerotic lesions correlates with calcium levels but does not protect against protein oxidation, Arterioscler Thromb Vasc Biol, 28, 1024, 10.1161/ATVBAHA.108.162735 Mori, 1999, An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry, Anal Biochem, 268, 117, 10.1006/abio.1998.3037 Vogt, 2003, MAPS: a set of software tools for analysis and visualization of 3D X-ray fluorescence data sets, J Phys IV, 104, 635 Easter, 2010, Vascular metallomics: copper in the vasculature, Vasc Med, 15, 61, 10.1177/1358863X09346656 Rowe, 2011, Short-term hyperglycemia increases arterial superoxide production and iron dysregulation in atherosclerotic monkeys, Metabolism, 10.1016/j.metabol.2010.11.003 Konijn, 1977, Ferritin synthesis in inflammation. I. Pathogenesis of impaired iron release, Br J Haematol, 37, 7 Blazewicz, 2010, Use of ion chromatography for the determination of selected metals in blood serum of patients with type 2 diabetes, J Trace Elem Med Biol, 24, 14, 10.1016/j.jtemb.2009.08.001 Liu, 2009, Role of iron deficiency and overload in the pathogenesis of diabetes and diabetic complications, Curr Med Chem, 16, 113, 10.2174/092986709787002862 Chait, 2009, Diabetes and atherosclerosis: is there a role for hyperglycemia?, J Lipid Res, 50, S335, 10.1194/jlr.R800059-JLR200 Ford, 2010, Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence, J Am Coll Cardiol, 55, 1310, 10.1016/j.jacc.2009.10.060 Kolodgie, 2004, Pathologic assessment of the vulnerable human coronary plaque, Heart, 90, 1385, 10.1136/hrt.2004.041798 Nicholls, 2008, Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials, J Am Coll Cardiol, 52, 255, 10.1016/j.jacc.2008.03.051 Lundby-Christensen, 2010, Carotid intima-media thickness in individuals with and without type 2 diabetes: a reproducibility study, Cardiovasc Diabetol, 9, 40, 10.1186/1475-2840-9-40 Mehta, 2006, Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction, Int J Biochem Cell Biol, 38, 794, 10.1016/j.biocel.2005.12.008 Colak, 2005, Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications, Ann Med, 37, 613, 10.1080/07853890500330193